Company Filing History:
2 out of 9 
2 out of 99 
Years Active: 2020-2023
Title: Munitta Muthana: Innovator in Oncolytic Virus Research
Introduction
Munitta Muthana is a prominent inventor based in Sheffield, GB. He has made significant contributions to the field of cancer treatment through his innovative research. With a total of 2 patents, Muthana is recognized for his work on oncolytic herpes simplex virus infected cells.
Latest Patents
Muthana's latest patents focus on the use of oncolytic herpes simplex virus infected cells. These patents disclose a monocyte, monocyte-derived cell, or macrophage infected with an oncolytic herpes simplex virus. The applications of these infected cells are aimed at treating diseases such as cancer, showcasing the potential of this research in therapeutic settings.
Career Highlights
Throughout his career, Munitta Muthana has worked with notable organizations, including Virttu Biologics Limited and the University of Sheffield. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Muthana has collaborated with several professionals in his field, including Joe Conner and Claire Elizabeth Lewis. These collaborations have further enriched his research and expanded the impact of his innovations.
Conclusion
Munitta Muthana's contributions to the field of oncolytic virus research highlight his role as an influential inventor. His patents and collaborations reflect his commitment to advancing cancer treatment through innovative solutions.